IDEXX Laboratories

Traded on the St. Petersburg Stock Exchange
IDEXX Laboratories, Inc. is an American multinational corporation engaged in the development, manufacture, and distribution of products and services for the companion animal veterinary, livestock and poultry, water testing, and dairy markets.
IDEXX Laboratories stock price chart
vol.
change
P/E
Net profit
P/B
Book value
P/FCF
FCF
Yield
Growth potential

IDEXX Laboratories balance sheet

Report period2018 2019 2020 2021 20222023
End date of the reporting period
Capitalization, $
Capitalization, $
Enterprise Value
Book Value
Shareholders Book Value
Current liabilities
Noncurrent liabilities
Total liabilities
Debt
Cash and cash equivalents
Net debt
Assets
Total ordinary shares
Ordinary share price

IDEXX Laboratories cash flows

Report period2018 2019 2020 2021 20222023
End date of the reporting period
Sales
Gross profit
Operation Income
Earnings
Shareholders earnings
EBITDA
Operation Cashflow
Capital expenditure
Free Cash Flow
EPS

IDEXX Laboratories multipliers

Report period2018 2019 2020 2021 20222023
P/E
E/P
P/B
P/S
P/FCF
L/A
Debt-To-Equity
Net Debt/EBITDA
EV/EBITDA

IDEXX Laboratories profitability

Report period2018 2019 2020 2021 20222023
ROA
ROE
ROS
Gross margin
EBITDA Margin
Operating margin
IDEXX Laboratories assets
IDEXX Laboratories cash flows

IDEXX Laboratories shares

TickerNameTypeNominal valueISINPrice
IDXX:USIDEXX Laboratories Inc.Common share-US45168D1046$463.9
IDEXX Laboratories news
02.02.2022
IDEXX Laboratories' GAAP net income for 2021 was $744.844 million, up 28% from $582.131 million in the previous year. Revenues increased 18.8% to $3.215 billion from $2.707 billion a year earlier.
Source: idexx.com pictogram idexx.com
Pictogram next
02.11.2021
Net income of IDEXX Laboratories under GAAP for nine months of 2021 was $582.073 million, up 43% from $407.173 million in the previous year. Revenues increased 21.6% to $2.414 billion from $1.986 billion a year earlier.
Source: idexx.com pictogram idexx.com
Pictogram next
30.07.2021
IDEXX Laboratories' GAAP net income for 6 months of 2021 was $406.895 million, up 56% from $260.852 million in the previous year. Revenue increased 26.9% to $1.604 billion from $1.264 billion a year earlier.
Source: idexx.com pictogram idexx.com
Pictogram next
03.06.2021
IDEXX Laboratories is acquiring ezyVet, developer of the cloud-based information management system of the same name for veterinary clinics. Terms of the deal were not disclosed.
Source: idexx.com pictogram idexx.com
Pictogram next
All IDEXX Laboratories news
General information
Company nameIDEXX Laboratories
Tags#s&p500 index
SectorHealth Care / Pharmaceuticals, Biotechnology & Life Sciences / Life Sciences Tools & Services / Life Sciences Tools & Services
Business addressONE IDEXX DRIVE WESTBROOK ME 04092-2041 2075560300
Mailing addressONE IDEXX DRIVE WESTBROOK ME 04092-2041
Websitewww.idexx.com
Information disclosurewww.sec.gov